Phase I clinical trial in patients with recurrent gliomas: delta-24-RGD oncolytic adenovirus induces an antiglioma immune-response

被引：0
|
作者：
Fueyo, J. [1 ]
Gomez-Manzano, C. [1 ]
Conrad, C. [1 ]
Heimberger, A. [1 ]
Vence, L. [1 ]
Aldape, K. [1 ]
Yung, W. A. [1 ]
Sawaya, R. [1 ]
Fuller, G. [1 ]
Lang, F. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF NEUROLOGY | 2012年 / 259卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S46 / S46
页数：1
相关论文
共 50 条
  • [41] A phase I clinical trial of Ad5/3-Δ24, a novel serotype-chimeric, infectivity-enhanced, conditionally-replicative adenovirus (CRAd), in patients with recurrent ovarian cancer
    Kim, Kenneth H.
    Dmitriev, Igor P.
    Saddekni, Souheil
    Kashentseva, Elena A.
    Harris, Raymond D.
    Aurigemma, Rosemarie
    Bae, Sejong
    Singh, Karan P.
    Siegal, Gene P.
    Curiel, David T.
    Alvarez, Ronald D.
    [J]. GYNECOLOGIC ONCOLOGY, 2013, 130 (03) : 518 - 524
  • [42] Identifying the safety profile of Ad5.SSTR/TK.RGD, a novel infectivity-enhanced bicistronic adenovirus, in anticipation of a phase I clinical trial in patients with recurrent ovarian cancer and other selected gynecologic cancers
    Matthews, K. S.
    Noker, P.
    Tian, B.
    Grimes, S.
    Fulton, R.
    Schweikart, K.
    Harris, R.
    Aurigemma, R.
    Wang, M.
    Curiel, D. T.
    Alvarez, R. D.
    [J]. GYNECOLOGIC ONCOLOGY, 2009, 112 (02) : S111 - S112
  • [43] Autologous adoptive immune-cell therapy elicited a durable response with enhanced immune reaction signatures in patients with recurrent glioblastoma: An open label, phase I/IIa trial
    Lim, Jaejoon
    Park, YoungJoon
    Ahn, Ju Won
    Sim, JeongMin
    Kang, Su Jung
    Hwang, Sojung
    Chun, Jin
    Choi, Hyejeong
    Kim, Sang Heum
    Chun, Duk-Hee
    Sung, Kyoung Su
    Kwack, KyuBum
    Cho, Kyunggi
    [J]. PLOS ONE, 2021, 16 (03):
  • [44] AUTOLOGOUS ADOPTIVE IMMUNE-CELL THERAPY ELICITED A DURABLE RESPONSE WITH ENHANCED IMMUNE REACTION SIGNATURES IN PATIENTS WITH RECURRENT GLIOBLASTOMA: AN OPEN LABEL, PHASE I/IIA TRIAL
    Lim, Jaejoon
    Park, Young Joon
    Ahn, Ju Won
    Sim, Jeong Min
    Kim, Suwan
    Hwang, Sojung
    Sung, Kyungsu
    Cho, Kyunggi
    [J]. NEURO-ONCOLOGY, 2021, 23 : 49 - 49
  • [45] Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: results of a clinical phase I/II trial
    R Yamanaka
    T Abe
    N Yajima
    N Tsuchiya
    J Homma
    T Kobayashi
    M Narita
    M Takahashi
    R Tanaka
    [J]. British Journal of Cancer, 2003, 89 : 1172 - 1179
  • [46] Vaccination against RhoC induces long-lasting immune responses in patients with prostate cancer: results from a phase I/II clinical trial
    Schuhmacher, Juliane
    Heidu, Sonja
    Balchen, Torben
    Richardson, Jennifer Rebecca
    Schmeltz, Camilla
    Sonne, Jesper
    Schweiker, Jonas
    Rammensee, Hans-Georg
    Thor Straten, Per
    Roder, Martin Andreas
    Brasso, Klaus
    Gouttefangeas, Cecile
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [47] Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: Results of a clinical phase I/II trial
    Yamanaka, R
    Homma, J
    Yajima, N
    Tsuchiya, N
    Tanaka, R
    [J]. MOLECULAR THERAPY, 2004, 9 : S98 - S98
  • [48] Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: results of a clinical phase I/II trial
    Yamanaka, R
    Abe, T
    Yajima, N
    Tsuchiya, N
    Tsuchiya, N
    Homma, J
    Kobayashi, T
    Narita, M
    Takahashi, M
    Tanaka, R
    [J]. BRITISH JOURNAL OF CANCER, 2003, 89 (07) : 1172 - 1179
  • [49] Phase I trial of intratumoral administration of OBP-301, a novel telomerase-specific oncolytic virus, in patients with advanced solid cancer: Evaluation of biodistribution and immune response
    Fujiwara, T.
    Tanaka, N.
    Nemunaitis, J. J.
    Senzer, N. N.
    Tong, A.
    Ichimaru, D.
    Shelby, S. M.
    Hashimoto, Y.
    Kawamura, H.
    Urata, Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [50] Toxicology study of repeat intracerebral administration of a measles virus derivative producing carcinoembryonic antigen in rhesus macaques in support of a phase I/II clinical trial for patients with recurrent gliomas
    Myers, Rae
    Harvey, Mary
    Kaufmann, Timothy J.
    Greiner, Suzanne M.
    Krempski, James W.
    Raffel, Corey
    Shelton, Steven E.
    Soeffker, Diane
    Zollman, Paula
    Federspiel, Mark J.
    Blanco, Michael
    Galanis, Evanthia
    [J]. HUMAN GENE THERAPY, 2008, 19 (07) : 690 - 698
12345